Middle East and Africa Active Pharmaceutical Ingredient Market

Middle East and Africa Active Pharmaceutical Ingredient Market Size

As per the research report published by research Cosmos, The Middle East and Africa (MEA) Active Pharmaceutical Ingredient (API) market size was estimated at USD 47.15 billion in 2018 and is estimated to expand at a CAGR of 15.8% over the forecast years 2024

Growth Opportunities, Challenges and Restraints of Middle East and Africa Active Pharmaceutical Ingredient Market

Improvements in API manufacturing and growth of the biopharmaceutical sector are anticipated to be the key factors driving the market. In extension, increasing geriatric population across the MEA is also expected to contribute to the market growth.

Rising prevalence of infectious diseases and Hospital-Acquired Infections (HAIs) are anticipated to fuel the market growth during the forecast period. Furthermore, the rising number of cases of cardiovascular, neurological, and genetic disorders is anticipated to augment the growth further. Cardiovascular Disorders (CVDs) are the most prevalent cause of death across the MEA.

Targeted therapy is gaining popularity as it only aims at malignant cells. The characteristics, such as the minimum effect of the drug on noncancerous cells, and effectiveness controlled by these anti-cancerous drugs are the circumstances contributing to the market growth in this region.

API production needs huge capital amount as the process needs extremely systematic protocols. Thus, pharmaceutical firms can actually benefit from outsourcing API production, as it reduces the need for the labor force and installing expensive manufacturing systems. Strategic outsourcing allows companies to focus on their heart competencies, ultimately resulting in increased productivity. These circumstances are also projected to spur market growth.

Market Segmentation of Middle East and Africa Active Pharmaceutical Ingredient Market

Based on the type of synthesis, the synthetic segment led the overall market in 2018, in phases of revenue share, owing to the easy availability of raw materials and easy procedures of synthesis. The biotech molecule was anticipated to be the fastest-growing application segment and is anticipated to register a CAGR of 7.5% during the forecast years. The share growth is driven by factors, such as growing demand for biopharmaceuticals and higher performance of these molecules. Moreover, technological improvements in the manufacturing processes will boost growth further.

Based on the manufacturer type, the captive segment held the largest share in 2018 owing to fast capitalization of major key companies in the development of high-end manufacturing plants and the availability of raw materials. Merchant API segment is supposed to be the fastest-growing segment owing to factors, such as increasing demand for biopharmaceuticals and high cost of in-house manufacturing of these molecules. In extension, since the captive production of APIs is high, companies have started opting for outsourcing.

Based on type, Innovative drugs section led the market in 2018 due to improved R&D initiatives for novel drug development and positive government regulations. The rising number of new entrants in this section is also expected to propel the market growth. Generic drug segment is expected to be the second fastest-growing part due to factors, such as patent expiry of branded drugs and lower price. The segment is likely to observe growth in developing countries due to unmet clinical needs and great acceptance levels for OTC drugs.

Based on application, Cardiology division led the market in 2018, owing to the growing prevalence of target diseases worldwide. According to the WHO, CVDs, especially heart attack and stroke, account for around 17.5 million deaths across the globe, including those in the MEA. Cardiovascular disorder is one of the critical public health burdens, qualified for extensive R&D for APIs in the field.

Regional Existence of Middle East and Africa Active Pharmaceutical Ingredient Market

Geographically, the MEA active pharmaceutical ingredients market is segmented into Saudi Arabia, South Africa, UAE, Egypt, Nigeria, and Rest of MEA.

The Middle East nations led the market in 2018, owing to technological improvements coupled with high economic development in the region. Rising prevalence of cancer and other lifestyle-induced conditions is encouraging the R&D activities, thereby boosting the market growth. UAE is estimated to be the fastest-growing region over the projected period. Availability of cheap labor and lenient regulatory framework are attracting foreign nations to set up manufacturing facilities in MEA.

Teva Pharmaceutical Industries Ltd. is a principal producer of generic medicines and a recognized master in innovative and specialty pharmaceuticals worldwide. Around 1,000 customers in over 100 countries use Teva’s active pharmaceutical components (API). The company produces high-quality and patient-centric health care solutions. It has a wide generic commodity portfolio, with more than 1,000 molecules in almost all therapeutic area.

 Some of the promising companies leading the Middle East and Africa Active Pharmaceutical Ingredient Market:

• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH
• Cipla, Inc.
• AbbVie, Inc.
• Merck & Co., Inc.
• Albemarle Corporation
• Bristol-Myers Squibb Company
• Mylan N.V.
• Sun Pharmaceutical Industries Ltd.
• Aurobindo Pharma
• Dr. Reddy’s Laboratories Ltd.

This research report includes following segmentation for the Middle East and Africa Active Pharmaceutical Ingredient Market size and forecast

Middle East and Africa Active Pharmaceutical Ingredient Market - By Type

• Generic APIs
• Innovative APIs

Middle East and Africa Active Pharmaceutical Ingredient Market - By Application

• Cardiology
• Oncology
• CNS
• Neurology
• Endocrinology

Middle East and Africa Active Pharmaceutical Ingredient Market - By Type of synthesis

• Biotech Type

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines

• Synthetic Type

Middle East and Africa Active Pharmaceutical Ingredient Market - By Manufacturer type

• Captive APIs
• Merchant APIs

Middle East and Africa Active Pharmaceutical Ingredient Market – By Region

• Middle East
• Africa